Quantcast Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX® - Congoo
 
Web  |  Images  |  News
 
News HomeUSWorldBusinessFinanceIndustryTechnologyScienceMedia & AdvertisingPolitics/LawEntertainmentInternetHealthSportsCulture
MEDIA Log In
Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX®
Have an interest in this Story?
Sign Up for Real-Time email updates
Freshnews.com  | November 05, 2009
Companies mentioned in this article: Pfizer Inc SAN DIEGO -- (BUSINESS WIRE) -- New study results showed that 42.3 percent of smokers with mild-to-moderate chronic obstructive pulmonary disease (COPD) who took CHANTIX/CHAMPIX® (varenicline) were able to quit smoking and remain abstinent during the ...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Niladri Roy Niladri Roy
Manager-International Marketing
Computer Services
Martin P. Lee Martin P. Lee
Associate Lecturer
Knowledge Management
  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.
Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.